会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Cycloheptenopyridine derivatives, process for preparation thereof and
antiulcer agents containing the same
    • 环庚烯并吡啶​​衍生物,其制备方法和含有它们的抗溃疡剂
    • US5149702A
    • 1992-09-22
    • US618943
    • 1990-11-27
    • Shin-ichi YamadaTakao GotoRie YoritaEizi ShimanukiTakaji YamaguchiKentaro KogiSenichi Narita
    • Shin-ichi YamadaTakao GotoRie YoritaEizi ShimanukiTakaji YamaguchiKentaro KogiSenichi Narita
    • C07D401/12C07D471/04
    • C07D401/12C07D471/04Y02P20/55Y10S514/926Y10S514/927
    • Provided are cycloheptenopyridine derivatives represented by the general formula ##STR1## [wherein R represents a hydrogen atom or lower alkyl group; R.sup.1 represents a hydrogen atom, halogen atom, lower cycloalkoxy group, amido group, substituted phenoxy group, substituted benzyloxy group, lower alkoxy group optionally containing halogen atoms(s), nitro group, hydroxyl group, lower alkenyloxy group, lower alkylthio group, or a group--NR.sup.4 R.sup.5 (wherein R.sup.4 and R.sup.5 may be the same or different and each represent a hydrogen atom or lower alkyl group, or R.sup.4 and R.sup.5 mutually combine together with the nitrogen atom adjacent thereto to form a 5- or 6-membered heterocyclic group); R.sup.2 represents a hydrogen atom, halogen atom, lower alkyl group optionally containing a halogen atom, lower alkoxy group optionally containing a halogen atom, hydroxyl group, acyl group, lower alkoxycarbonyl group, nitro group or amino group; R.sup.3 represents a hydrogen atom, a lower alkyl group, lower alkoxymethyl group, lower alkylcarbonyl group, lower alkoxycarbonyl group, carbamoyl group, lower alkylcarbamoyl group, lower alkylcarbonylmethyl group, lower alkoxycarbonyl group, lower acyloxymethyl group, lower alkylsulfonyl group, or physiologically acceptable protective group eliminatable in an acid medium or under a physiological condition; n represents 0 or 1; and A represents a methine carbon or nitrogen atom] or their salts. These derivatives and their salts are useful as antiulcer agents.
    • 提供由通式[IMAGE] [I]表示的环庚烯并吡啶​​衍生物[其中R表示氢原子或低级烷基; R1表示氢原子,卤素原子,低级环烷氧基,酰胺基,取代苯氧基,取代的苄氧基,任选含有卤原子的低级烷氧基,硝基,羟基,低级链烯氧基,低级烷硫基,或 基团-NR 4 R 5(其中R 4和R 5可以相同或不同,各自表示氢原子或低级烷基,或者R 4和R 5与与其相邻的氮原子相互结合形成5-或6-元杂环基 ); R2表示氢原子,卤素原子,任选含有卤原子的低级烷基,任选含有卤素原子的低级烷氧基,羟基,酰基,低级烷氧基羰基,硝基或氨基; R3表示氢原子,低级烷基,低级烷氧基甲基,低级烷基羰基,低级烷氧基羰基,氨基甲酰基,低级烷基氨基甲酰基,低级烷基羰基甲基,低级烷氧基羰基,低级酰氧基甲基,低级烷基磺酰基或生理上可接受的保护性 组在酸性培养基中或在生理条件下可消除; n表示0或1; A表示次甲基碳或氮原子]或其盐。 这些衍生物及其盐可用作抗溃疡剂。
    • 4. 发明授权
    • Prostacyclin analogue, and blood circulation improving agent and
anti-ulcer composition containing it as active ingredient
    • US4837342A
    • 1989-06-06
    • US14591
    • 1987-02-13
    • Masakatsu ShibasakiAtsuo TakahashiTuyoshi AokiKentaro KogiYozo NishimiyaTakeshi NaraTakashi Yamaguchi
    • Masakatsu ShibasakiAtsuo TakahashiTuyoshi AokiKentaro KogiYozo NishimiyaTakeshi NaraTakashi Yamaguchi
    • C07C405/00
    • C07C405/0083
    • A prostacyclin analogue having the formula: ##STR1## wherein R.sup.1 is --CO.sub.2 R.sup.5 (wherein R.sup.5 is a hydrogen atom, a straight chain or branched alkyl group having from 1 to 12 carbon atoms, an aralkyl group having from 7 to 12 carbon atoms, a cycloalkyl group having from 4 to 7 carbon atoms and unsubstituted or substituted by at least one alkyl group having from 1 to 4 carbon atoms, a substituted or unsubstituted phenyl group, or one equivalent of a cation), or --CONR.sup.6 R.sup.7 (wherein each of R.sup.6 and R.sup.7 is a hydrogen atom or an alkyl group having from 1 to 10 carbon atoms, or R.sup.6 and R.sup.7 together with the adjacent nitrogen atom, form a 5- or 6-membered substituted or unsubstituted hetero ring which may contain a hetero atom other than said nitrogen atom); A is --CH.sub.2 CH.sub.2 CH.sub.2 --, CH.sub.2 --O--CH.sub.2 CH.sub.2 --, --CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.2 --, --CH.sub.2 CH.sub.2 --O--CH.sub.2 -- or --CH.dbd.CHCH.sub.2 CH.sub. 2 --; B is trans --CH.dbd.CH-- or --C.tbd.C--; R.sup.2 is a straight chain or branched alkyl group having from 3 to 10 carbon atoms, a cycloalkyl group having from 4 to 7 carbon atoms and unsubstituted or substituted by at least one alkyl group having from 1 to 4 carbon atoms, a straight chain or branched alkenyl group having from 3 to 12 carbon atoms, a straight chain or branched alkynyl group having from 3 to 8 carbon atoms, or an alkyl group having from 1 to 3 carbon atoms substituted by a substituted or unsubstituted phenyl or phenoxy group, by an alkoxy group having from 1 to 6 carbon atoms or by a cycloalkyl group having from 5 to 8 carbon atoms; R.sup.3 is a hydrogen atom, a methyl group or a vinyl group; and R.sup.4 is a hydrogen atom, an acyl group having from 1 to 7 carbon atoms, a tri-C.sub.1 -C.sub.7 hydrocarbon-silyl group or a group capable of forming an acetal bond together with the oxygen atom of a hydroxyl group; provided that the double bond in a substituent for A is E or Z, or a mixture thereof; the asymmetric center in a substituent for R.sup.2 assumes a R-conformation or a S-conformation, or a mixture thereof; and the bonds shown by dotted lines at the 2-3 and 3-4 positions mean that either one of them is a double bond.
    • 8. 发明授权
    • Tri-O-acetyl-2-alkynyladenosines
    • 三-O-乙酰基-2- alkynyladenosines
    • US5283327A
    • 1994-02-01
    • US655354
    • 1991-04-17
    • Toyofumi YamaguchiToichi AbiruAkira MatsudaTohru UedaKentaro Kogi
    • Toyofumi YamaguchiToichi AbiruAkira MatsudaTohru UedaKentaro Kogi
    • C07H19/16C07H19/167
    • C07H19/16Y02P20/55
    • The present invention relates to a novel compound represented by the following formula [I] which is useful as a synthetic intermediate of a 2-alkynyladenosine.The present invention also relates to a process for producing the compound and a process for producing a 2-alkynyladenosine [IV] by way of the compound.Further, the present invention relates to a 2-alkynyladenosine derivative represented by the following formula [V] having excellent storage stability and, to a method of storing the 2-alkynyladenosine in the form of that derivative. ##STR1## wherein R.sup.1 through R.sup.4 represent a hydrogen atom or a protective group, and n denotes an integer of 1 to 15, provided that R.sup.1 through R.sup.4 do not represent a hydrogen atom simultaneously.
    • PCT No.PCT / JP90 / 00807 Sec。 371日期:1991年4月17日 102(e)中的日期1991年4月17日提交的PCT 1990年6月20日的PCT公布。 出版物WO90 / 15812 PCT 日本1990年12月27日。本发明涉及可用作2-炔基腺苷合成中间体的下式(I)表示的新化合物。 本发明还涉及该化合物的制备方法和通过该化合物制备2-炔基腺苷(Ⅳ)的方法。 此外,本发明涉及具有优异储存稳定性的下式(V)表示的2-链炔基腺苷衍生物,以及以该衍生物的形式存储2-炔基腺苷的方法。 (*化学结构*)(*化学结构*)其中R1至R4表示氢原子或保护基,n表示1至15的整数,条件是R1至R4同时不表示氢原子。